Selected Grants
EPCTU - Task Area A - Option 2
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2032Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2027Lipid Metabolite Profiles and Cardiovascular Events in Persons with HIV (PWH) who have Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
ResearchMentor · Awarded by American College of Gastroenterology · 2024 - 2027Duke Training Grant in Digestive Diseases and Nutrition
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1988 - 2027Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis
Clinical TrialCollaborator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2021 - 2026NIAID Virology Quality Assurance - Year 6 Option 5
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2026HERO Program, HERO Registry, HERO-HCQ Trial
Clinical TrialPI/Director · Awarded by Patient-Centered Outcomes Research Institute · 2020 - 2025Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025TDE Pickett Road Infrastructure
Institutional SupportPrincipal Investigator · Awarded by Duke Endowment · 2021 - 2025Center for AIDS Research
ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2005 - 2025Ancillary Studies of NAFLD and NASH in HIV infected Adults (Fixed Cost Contract) (CR# 267421)
ResearchPrincipal Investigator · Awarded by Indiana University · 2021 - 2025Ancillary Studies of NAFLD and NASH in HIV infected Adults (R01)
ResearchPrincipal Investigator · Awarded by Indiana University · 2020 - 2025Spatial transcriptomic profiling to assess liver fibrosis pathways associated with HIV infection
ResearchPrincipal Investigator · Awarded by St. Louis University · 2023 - 2025VTEU 14-0053 Task C Option 2 Protocol Implementation
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2024VTEU: Task Area D: Research Laboratory Analysis Protocol #14-0053
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2024Unified Program for Therapeutics in Children
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2019 - 2024Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV (R01)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2024Ancillary Studies of NAFLD and NASH in HIV infected Adults
Clinical TrialPrincipal Investigator · Awarded by The Trustees of Indiana University · 2022 - 2023VTEU 14-0053 Task C Option 4 Protocol Implementation
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2023VTEU 14-0053 Task C Option 3 Protocol Implementation
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2015 - 2023Leadership and Operations Center (LOC) AIDS Clinical Trials Group (ACTG) Protocol Chair Support for A5380
ResearchPrincipal Investigator · Awarded by University of California - Los Angeles · 2018 - 2023Rapid diagnosis and quantification of HIV by direct capture, labelling and detection of individual virions
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2023Randomized Trial to Prevent Vascular Events in HIV- REPRIEVE (A5332)
Clinical TrialPrincipal Investigator · Awarded by Massachusetts General Hospital · 2015 - 2023A Multidisciplinary Approach to Primary Cardiovascular Disease Prevention in HIV-infected (K23)
ResearchMentor · Awarded by National Institutes of Health · 2018 - 2022Leadership and Operations Center (LOC), Aids Clinical Trial Group (ACTG) HEP Committee Chair - Transformative Science Group
ResearchPrincipal Investigator · Awarded by University of California - Los Angeles · 2020 - 2021Janssen HERO Vaccine Trial Start Up Budget
Clinical TrialCo Investigator · Awarded by Janssen Pharmaceutica, Inc. · 2020 - 2020Leadership and Operations Center (LOC), Aids Clinical Trial Group (ACTG) HEP Committee Chair
ResearchPrincipal Investigator · Awarded by University of California - Los Angeles · 2018 - 2020HCV/HIV Co-infection Registry
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2015 - 2020First-in-human (FIH) Safety and Dose Ranging Study of TT-034 in Patients with Chronic Hepatitis C (CHC) Infection
Clinical TrialPrincipal Investigator · Awarded by Tacere Therapeutics · 2014 - 2019VTEU 14-0053 Task Area A Project Logistics and Site Activation
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2019M16-135
Clinical TrialPrincipal Investigator · Awarded by AbbVie Inc. · 2017 - 2019VTEU: Task Area C: Protocol Implementation - Option 2 Protocol #14-0053
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2019RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse
ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2019The Follow Up Study Regarding the Safety and Efficacy of TT-034, a Genetically-Modified Adeno-Associated Virus Designed to Target Hepatitis C in a Study Under Protocol B2801001.
Clinical TrialPrincipal Investigator · Awarded by Tacere Therapeutics · 2014 - 2019ACTG, Aids Clinical Trials Group Hepatitis TSG Vice-Chair
ResearchPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2015 - 2018mHealth Peer Support to Reduce Rates of STIs in Black MSM PrEP Users
ResearchMentor · Awarded by National Institutes of Health · 2018 - 2018Systems Biology Approaches for Predicting Cardiometabolic Risk in Persons Living with HIV
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2015 - 2018GS-US-366-1992
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2016 - 2018ACTG A5327 Protocol Chair Support (PCS)
ResearchPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2015 - 2017VTEU: Base -Task Area A: Project Logistics and Site Activation Protocol #14-0053
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2017A phase3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination for 12 weeks in Subjcts with Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2015 - 2017Gilead GS-342-1553 A randomized, open-label study to evaluate the efficacy and safety of Sofosbuvir/GS-5816 Fixed Dose Combination - Ribavirin for 24 weeks in Chronic HCV infected subjects who participated in a prior Gilead-sponsored HCV study.
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2014 - 2017GS_US_342-1140
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2014 - 2017VTEU: Option 1-Task Area B: Protocol Development Protocol #14-0053
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2016The Pharmacokinetics of Extended Duration High-dose Cefixime Co-administered with Azithromycin for the Decreased Susceptibility of Neisseria gonorrhoeae: A Phase I Pilot Study
Clinical TrialCollaborator · Awarded by National Institutes of Health · 2015 - 2016Phase 3 multicenter, open-label study to investigate the efficacy and safety of Sofosbuvir/Ledipasvir fixed-dose combination for 12 weeks in subjects with chronic genotype 1 or 4 HCV and HIV-1 co-infection
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2014 - 2016ACTG, Aids Clinical Trials Group
ResearchPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2015 - 2015Moving Towards More Individualized Therapies in HIV/HCV Co-infected Patients
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2015Collaboration between Duke University and the NIAID
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2012External Relationships
- Bristol-Myers Squibb/PRA
- Clinical Infectious Diseases
- IAS-USA
- Pardes Biosciences
- Personal Health Insights, INC
- Vir Biotechnology
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.